| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/29/2000 | CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 11/29/2000 | CN1274757A Oligonucleotide primer for effective detection of hepatitis C virus (HCV) and its use |
| 11/29/2000 | CN1274755A Human protein kinase inhibitor II and its code sequence, preparation process and application |
| 11/29/2000 | CN1274726A Human tobule related protein 1A/1B light chain 3 and its code sequence, preparation and application |
| 11/28/2000 | US6154707 Computer logic for fluorescence genotyping at multiple allelic sites |
| 11/28/2000 | US6153743 Lithographic mask design and synthesis of diverse probes on a substrate |
| 11/28/2000 | US6153740 Polynucleotide sequence coding a transport polypeptide; for the treatment of human tumors and viral diseases; antitumor agents |
| 11/28/2000 | US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase |
| 11/28/2000 | US6153737 Derivatized oligonucleotides having improved uptake and other properties |
| 11/28/2000 | US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies |
| 11/28/2000 | US6153599 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression |
| 11/28/2000 | US6153595 Composition and method for treatment of CMV infections |
| 11/28/2000 | US6153583 OP-3 induced morphogenesis |
| 11/28/2000 | US6153430 Used as indicator of the presence of ovarian cancer tumor cells |
| 11/28/2000 | US6153429 Cell lines useful for in vitro assay for indentification of carcinogens |
| 11/28/2000 | US6153425 Apparatus for the isolation and amplification nucleotide sequences; for the accurate and efficient detection of nucleotide sequences |
| 11/28/2000 | US6153419 Method for quantitative determination of 1,5-anhydroglucitol |
| 11/28/2000 | US6153417 CSAPK-1 protein and uses therefor |
| 11/28/2000 | US6153411 Simple, sensitive, quantitative process for aqueous samples; concentrating organisms present using separation technique, amplifying target nucleic acid using primers of defined nucleotide sequence, detecting amplified nucleic acid acid |
| 11/28/2000 | US6153410 Recombination of polynucleotide sequences using random or defined primers |
| 11/28/2000 | US6153401 Microorganisms and plasmids for 2,4-dichlorophenoxyacetic acid (2,4-D) monooxygenase formation and process for the production of these plasmids and strains |
| 11/28/2000 | US6153400 Device and method for microbial antibiotic susceptibility testing |
| 11/28/2000 | US6153399 Determining ascorbic acid using ASOD and LEUCO chromogen |
| 11/28/2000 | US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis |
| 11/28/2000 | US6153389 Collecting sample, introducing fragment of dna of known length and sequence into the sample; dna fragment does not interfere with subsequent analysis; label for forensic or medical samples including blood, semen, saliva, urine, tissue |
| 11/28/2000 | US6153388 Accurate diagnosis and staging by extacting messenger rna from lymph node tissue, producing cdna, increasing quantity of tyrosinase cdna present; presence of tyrosinase cdna indicates presence of melanocytes |
| 11/28/2000 | US6153386 Analyzing the dna sequence of the angiotensinogen gene; mutation a-20c indicates a greater predisposition or a more severe hypertension |
| 11/28/2000 | US6153385 Quantifying by isolating rna from cells, transcribing into cdna, amplifying cdna and competitor fragment using ligand-specific primers of defined nucleotide sequence, comparing amounts of ligand and competitor product |
| 11/28/2000 | US6153384 High throughput screening assays for nucleic acid ligase modulators |
| 11/28/2000 | US6153381 Screening for antibiotics |
| 11/28/2000 | US6153380 In vitro mehtod by introducing library of random nucleic acids into cells to produce peptides, screening for cells exhibiting an altered phenotype; better intracellular localization of peptides |
| 11/28/2000 | US6153379 Immobilizing known oligonucleotides to solid support, hybridizing polynucleotide of interest, extending primers by single terminating nucleotide, observing location and identity of each terminating nucleotide |
| 11/28/2000 | US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus |
| 11/28/2000 | US6153376 Drug screening for fungicides by incubating enzyme from saccharomyces cerevisiae with specific substrate in presence of test compound; absence of specific o- or n-linked oligosaccharides indicates enzyme inhibitor |
| 11/28/2000 | US6153375 Making combinatorial libraries by using specific solid support and then repeatedly adding reagent, recording identify of zones, and subdividing batches |
| 11/28/2000 | US6153374 Drug screening to identify enzyme inhibitors by incubating enzyme and substrate in presence and absence of compound and evaluating activity |
| 11/28/2000 | US6153189 Human TRK receptors and neurotrophic factor inhibitors |
| 11/28/2000 | US6152358 Bioluminescent novelty items |
| 11/28/2000 | CA2308259A1 Method for assaying the function of flaa1 and wbpm |
| 11/28/2000 | CA2307357A1 Wbpp and method for assay of wbpp |
| 11/28/2000 | CA2305716A1 Method for assay of wbpm |
| 11/28/2000 | CA2121659C Sample processing method for mycobacteria |
| 11/28/2000 | CA2066428C Structural alterations of the egf receptor gene in human gliomas |
| 11/28/2000 | CA2019475C Process for measuring the biological activity of a soil |
| 11/28/2000 | CA2016358C Method for the synthesis of ribonucleic acid (rna) |
| 11/23/2000 | WO2000070353A2 High throughput assay systems and methods |
| 11/23/2000 | WO2000070349A1 Identifying material from a breast duct |
| 11/23/2000 | WO2000070348A1 Methods for predicting and/or diagnosing the risk of gastric cancer |
| 11/23/2000 | WO2000070345A1 Reversible immobilization of ligands onto metal surfaces, their preparation and use in biochemical applications |
| 11/23/2000 | WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 11/23/2000 | WO2000070329A1 Nucleic acid-based detection |
| 11/23/2000 | WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 11/23/2000 | WO2000070098A1 Microarray-based subtractive hybridization |
| 11/23/2000 | WO2000070097A2 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 11/23/2000 | WO2000070096A2 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| 11/23/2000 | WO2000070095A2 Homogeneous isothermal amplification and detection of nucleic acids using a template switch oligonucleotide |
| 11/23/2000 | WO2000070093A1 Arrays with modified oligonucleotide and polynucleotide compositions |
| 11/23/2000 | WO2000070092A1 Expression of ets-domain proteins in cancer |
| 11/23/2000 | WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION |
| 11/23/2000 | WO2000070090A1 Process for high throughput dna methylation analysis |
| 11/23/2000 | WO2000070089A1 Cdx2 is downstream mediator of apc tumor suppressor activity |
| 11/23/2000 | WO2000070088A2 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 11/23/2000 | WO2000070086A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 11/23/2000 | WO2000070085A2 Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases |
| 11/23/2000 | WO2000070083A1 Assay for myelosuppression by farnesyl transferase inhibitors |
| 11/23/2000 | WO2000070082A1 Cell assay, method and reagents |
| 11/23/2000 | WO2000070081A1 Detection of viral stability |
| 11/23/2000 | WO2000070078A2 Method and device for determining the concentration of organisms |
| 11/23/2000 | WO2000070073A1 Method for sequencing nucleic acid molecules |
| 11/23/2000 | WO2000070069A1 Acquired resistance genes in plants |
| 11/23/2000 | WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY |
| 11/23/2000 | WO2000070049A2 Extracellular signaling molecules |
| 11/23/2000 | WO2000070047A2 Full-length molecules expressed in human tissues |
| 11/23/2000 | WO2000070046A2 Secreted polypeptides and corresponding polynucleotides |
| 11/23/2000 | WO2000070042A1 143 human secreted proteins |
| 11/23/2000 | WO2000070040A1 Cell concentration and lysate clearance using paramagnetic particles |
| 11/23/2000 | WO2000070036A2 Genes expressed in hippocampus |
| 11/23/2000 | WO2000070035A1 Inhibitors for viral infection targeting integrase n-terminal region |
| 11/23/2000 | WO2000070028A1 Sphingosine kinase enzyme |
| 11/23/2000 | WO2000070024A2 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 11/23/2000 | WO2000070011A1 Apparatus and method of testing a biological fluid |
| 11/23/2000 | WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 11/23/2000 | WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 11/23/2000 | WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 11/23/2000 | WO2000069899A1 Compositions of solvents and high concentrations of nucleic acid analogs |
| 11/23/2000 | WO2000069882A1 Genetic marker for meat quality, growth, carcass and reproductive traits in livestock |
| 11/23/2000 | WO2000069391A2 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 11/23/2000 | WO2000069262A1 NOVEL β-SECRETASE AND MODULATION OF β-SECRETASE ACTIVITY |
| 11/23/2000 | WO2000043410A3 Novel odorant receptors in drosophila |
| 11/23/2000 | WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides |
| 11/23/2000 | WO2000041558A3 Interspecific nicotiana hybrids and their progeny |
| 11/23/2000 | WO2000040759A3 Uses of flavivirus rna-dependent rna polymerases |
| 11/23/2000 | WO2000040752A3 Cancer associated genes and their products |
| 11/23/2000 | WO2000039581A3 Test system for detecting different markers, and production and use thereof |
| 11/23/2000 | WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression |
| 11/23/2000 | WO2000036124A3 Plant cell cycle genes and uses thereof |
| 11/23/2000 | WO2000034506A3 Method of screening candidate compounds for susceptibility to oxidative metabolism |
| 11/23/2000 | WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 11/23/2000 | WO2000029556A3 Identification of glycosphingolipids that promote hiv-1 entry into cells |
| 11/23/2000 | WO2000028057A3 PLANT AMINOACYL-tRNA SYNTHETASES |